INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR SYNERGIZE TO INDUCE NITRIC-OXIDE PRODUCTION AND INHIBIT MITOCHONDRIAL RESPIRATION IN VASCULAR SMOOTH-MUSCLE CELLS

被引:254
作者
GENG, Y [1 ]
HANSSON, GK [1 ]
HOLME, E [1 ]
机构
[1] GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT CLIN CHEM,S-41345 GOTHENBURG,SWEDEN
关键词
INTERFERON GAMMA; MITOCHONDRIA; NITRIC OXIDE; VASCULAR SMOOTH MUSCLE; TUMOR NECROSIS FACTOR;
D O I
10.1161/01.RES.71.5.1268
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nitric oxide (NO) is an important signal substance in cell-cell communication and can induce relaxation of blood vessels by activating guanylate cyclase in smooth muscle cells (SMCs). NO is synthesized from L-arginine by the enzyme NO synthase, which is present in endothelial cells. It was recently shown that SMCs may themselves produce NO or an NO-related compound. We have studied NO production and its effects on energy metabolism in cultured rat aortic smooth muscle cells. It was observed that the cytokines, interferon-gamma and tumor necrosis factor-alpha, synergistically induced an arginine-dependent production of NO in these cells. This was associated with an inhibition of complex I (NADH: ubiquinone oxidoreductase) and complex II (succinate:ubiquinone oxidoreductase) activities of the mitochondrial respiratory chain, suggesting that NO blocks mitochondrial respiration in these cells. Lactate accumulated in the media of the cells, implying an increased anaerobic glycolysis, but there was no reduction of viability. An NO-dependent inhibition of mitochondrial respiration and a switch to anaerobic glycolysis would reduce the energy production of the SMCs. This would in turn reduce the contractile capacity of the cell and might represent another NO-dependent vasodilatory mechanism. It could be of particular importance in inflammation, since cytokines released by inflammatory cells may induce autocrine NO production in SMCs.
引用
收藏
页码:1268 / 1276
页数:9
相关论文
共 47 条
[21]  
HYSLOP PA, 1988, J BIOL CHEM, V263, P1665
[22]   ENDOTHELIUM-DERIVED RELAXING FACTOR PRODUCED AND RELEASED FROM ARTERY AND VEIN IS NITRIC-OXIDE [J].
IGNARRO, LJ ;
BUGA, GM ;
WOOD, KS ;
BYRNS, RE ;
CHAUDHURI, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :9265-9269
[23]   NG-METHYL-L-ARGININE INHIBITS TUMOR NECROSIS FACTOR-INDUCED HYPOTENSION - IMPLICATIONS FOR THE INVOLVEMENT OF NITRIC-OXIDE [J].
KILBOURN, RG ;
GROSS, SS ;
JUBRAN, A ;
ADAMS, J ;
GRIFFITH, OW ;
LEVI, R ;
LODATO, RF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) :3629-3632
[24]   RHEUMATOID-ARTHRITIS [J].
KLARESKOG, L ;
RONNELID, J ;
GUDMUNDSSON, S ;
KARLSSONPARRA, A .
CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (06) :912-916
[25]   REGULATION OF GLYCOLYSIS IN RAT AORTA [J].
KUTCHAI, H ;
GEDDIS, LM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 247 (01) :C107-C114
[26]   LEBERS HEREDITARY OPTIC NEUROPATHY AND COMPLEX-I DEFICIENCY IN MUSCLE [J].
LARSSON, NG ;
ANDERSEN, O ;
HOLME, E ;
OLDFORS, A ;
WAHLSTROM, J .
ANNALS OF NEUROLOGY, 1991, 30 (05) :701-708
[27]   LACTIC ACID ASSAY WITH L(+)LACTIC ACID DEHYDROGENASE FROM RABBIT MUSCLE [J].
LUNDHOLM, L ;
VAMOS, N ;
MOHMELUNDHOLM, E .
ACTA PHYSIOLOGICA SCANDINAVICA, 1963, 58 (02) :243-&
[28]  
LYONS CR, 1992, J BIOL CHEM, V267, P6370
[29]   THE L-ARGININE - NITRIC-OXIDE PATHWAY [J].
MONCADA, S ;
HIGGS, EA ;
HODSON, HF ;
KNOWLES, RG ;
LOPEZJARAMILLO, P ;
MCCALL, T ;
PALMER, RMJ ;
RADOMSKI, MW ;
REES, DD ;
SCHULZ, R .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 :S1-S9
[30]   THE POTENT VASODILATING AND GUANYLYL CYCLASE ACTIVATING DINITROSYL-IRON(II) COMPLEX IS STORED IN A PROTEIN-BOUND FORM IN VASCULAR TISSUE AND IS RELEASED BY THIOLS [J].
MULSCH, A ;
MORDVINTCEV, P ;
VANIN, AF ;
BUSSE, R .
FEBS LETTERS, 1991, 294 (03) :252-256